Tango Therapeutics is a biotechnology company that develops targeted cancer therapies. The company's approach is based on a deep understanding of the genetic drivers of cancer, and it uses this knowledge to develop drugs that can selectively target cancer cells. Tango Therapeutics was founded in 2017 and is headquartered in Cambridge, Massachusetts. The company has partnerships with a number of other biotech and pharmaceutical companies, and it has received funding from a variety of sources, including venture capital firms and government agencies.